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Takashi Matsumoto, MD, Kazuaki Okuyama, MD, Wen Cheng, MD, Raj R. Makkar, MD, Saibal Kar, MDA n 81-year-old woman presented for a sched-uled 1-month follow-up after an uneventfulvalve-in-valve transapical transcatheter
aortic valve replacement (TA-TAVR) using a 23-mm
Sapien XT prosthesis (Edwards Lifesciences, Irvine,
California). Although the patient remained asymptom-
atic after discharge, a transthoracic echocardiogram
revealed a left ventricular (LV) pseudoaneurysm,
with a 10-mm neck, at the location of the transapicalFIGURE 1 Transthoracic Echocardiogram With Contrast (Apical 4-Ch
(A) Transthoracic echocardiogram with contrast at 1-month follow-up p
left ventricular (LV) pseudoaneurysm (asterisk) with a neck (Online Vide
pseudoaneurysm closure showed a well-seated 12-mm Amplatzer Muscul
the LV pseudoaneurysm without signiﬁcant shunt (Online Video 2).
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heart team discussion led to the decision to proceed
with percutaneous closure via an antegrade transsep-
tal approach. The procedure was performed under
general anesthesia and transesophageal echocardio-
graphic guidance. Following transseptal puncture, an
8-F Mullins sheath was further advanced into the LV
through the mitral valve with a support of a 6-F
balloon ﬂoating catheter, and then an initial LVamber View)
ost-transapical transcatheter aortic valve replacement revealed a
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FIGURE 2 Cine Angiography
(A) Initial left ventriculogram demonstrated left ventricular (LV) pseudoaneurysm with a neck. (B) A distal disk of the occluder device was
deployed. (C) A proximal disk of the occluder device was deployed. (D) The ﬁnal left ventriculogram showed occlusion of the pseudoaneurysm
with the 12-mm Amplatzer Muscular ventricular septal defect occluder.
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e178angiogram was performed (Figure 2A). A 6-F multipur-
pose catheter was manipulated into the pseudoaneur-
ysm; the catheter was then exchanged for an 80-cm
8-F Amplatzer TorqVue sheath (St. Jude Medical,
Minneapolis, Minnesota). On the basis of echocardio-
graphic and balloon-sizing measurement, a 12-mm
Muscular ventricular septal defect occluder (St. Jude
Medical) was prepared in standard fashion and
deployed successfully (Figures 2B and 2C). The ﬁnal
angiogram showed a well-seated device without sig-
niﬁcant shunt (Figure 2D). At discharge (post-operative
day 2), a transthoracic echocardiogram showed the
occluder device completely sealing the pseudoa-
neurysm (Figure 1B, Online Video 2).
LV pseudoaneurysm is a rare but serious complica-
tion after TA-TAVR (1). Percutaneous pseudoaneurysmclosure after TA-TAVR via a retrograde transfemoral
approach was previously reported (2), but this tech-
nique has some concerns, including the long access
route to the LV apex and potential risk of valve injury.
By contrast, the antegrade transseptal approach pro-
vides an appropriate access route, allowing the usage
of a standard delivery system for the occluder device,
and eliminates the risk of damaging the implanted
valve. Therefore, it is suggested that the present
technique be considered as the ﬁrst-line option for
LV pseudoaneurysm closure after TA-TAVR.
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